29 completed, 3 active not recruiting, 2 recruiting, 1 not yet recruiting. 32 Phase 1, 5 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 32 | Completed 27, Active not recruiting 2, Recruiting 1, Terminated 1, Withdrawn 1 |
| Early Phase 1 | 5 | Completed 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
Follow Atridia Pty Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of RLX-2508-102 in Healthy Volunteers RLX-2508 - Influenza | Early Phase 1 | Not yet recruiting | Atridia Pty Ltd. | 101 | 2026-11-15 | 2026-10-14 |
| A Trial of HRS-3095 in Healthy Volunteers HRS-3095 - Chronic Spontaneous Urticaria | Early Phase 1 | Recruiting | Atridia Pty Ltd. | 36 | 2026-07-27 | 2026-08-07 |
| A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative Cancer HRS-6209 Capsules and fulvestrant injection - Breast Cancer | Phase 1 | Recruiting | Atridia Pty Ltd. | 15 | 2026-05-15 | 2026-08-11 |
| A Trial of SHR-2173 in Healthy Volunteers SHR-2173 Injection/SHR-2173 placebo - Immunology | Phase 1 | Completed | Atridia Pty Ltd. | 18 | 2026-03-06 | 2026-10-14 |
| A Trial of HRS-5817 in Obese Participants HRS-5817 - Obesity | Early Phase 1 | Active not recruiting | Atridia Pty Ltd. | 40 | 2026-01-05 | 2026-05-12 |
| A Trial of SHR-1139 in Healthy Volunteers SHR-1139 Injection - Psoriasis | Phase 1 | Active not recruiting | Atridia Pty Ltd. | 24 | 2025-08-19 | 2026-03-19 |
| A Trial of HRS-1893 in Healthy Volunteers HRS-1893 - Hypertrophic Cardiomyopathy | Early Phase 1 | Completed | Atridia Pty Ltd. | 20 | 2025-06-25 | 2025-11-18 |
| A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer HRS-5041 Single dose of HRS-5041 orally administered - Metastatic Castration Resistant Prostate Cancer | Phase 1 | Active not recruiting | Atridia Pty Ltd. | 25 | 2025-06-15 | 2026-10-14 |
| A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors SHR-4602 - HER2-expressing or HER2-mutated Locally or Metastatic Solid Tumors | Phase 1 | Withdrawn | Atridia Pty Ltd. | 2025-03-01 | 2025-01-07 | |
| Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants HRS-5041 dose level 1, HRS-5041 dose level 2 - Prostate Cancer | Phase 1 | Completed | Atridia Pty Ltd. | 24 | 2024-09-25 | 2025-03-18 |
| Phase 1 Study of HRS-9231 Safety and Pharmacokinetics in Healthy Caucasians HRS-9231or matching placebo - MRI | Early Phase 1 | Completed | Atridia Pty Ltd. | 20 | 2024-08-21 | 2024-12-06 |
| A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease SHR-1707 injection, Placebo - Alzheimer's Disease (AD) | Phase 1 | Completed | Atridia Pty Ltd. | 2 | 2024-04-17 | 2025-07-11 |
| A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. HRS-7085 tablets, Placebo tablet - Inflammatory Bowel Disease | Phase 1 | Completed | Atridia Pty Ltd. | 16 | 2022-12-05 | 2023-04-21 |
| A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors SHR-1921 - Advanced Solid Tumor | Phase 1 | Completed | Atridia Pty Ltd. | 9 | 2022-12-01 | 2024-06-25 |
| Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors SHR-2002 and SHR-1316 - Advanced Malignant Tumors | Phase 1 | Completed | Atridia Pty Ltd. | 19 | 2021-11-23 | 2024-06-04 |
| A Trial of SHR-1905 in Healthy Subjects SHR-1905, Placebo - Asthma | Phase 1 | Completed | Atridia Pty Ltd. | 50 | 2021-07-27 | 2023-05-10 |
| A Trial of SHR-1703 in Healthy Subjects SHR-1703, Placebo - Asthma | Phase 1 | Terminated | Atridia Pty Ltd. | 1 | 2021-06-14 | 2021-12-01 |
| A Trial of SHR2285 in Healthy Subjects SHR2285 - Healthy Volunteers | Phase 1 | Completed | Atridia Pty Ltd. | 31 | 2021-05-20 | 2022-03-08 |
| A Trial of SHR-1707 in Healthy Young Adult and Elderly Subjects SHR-1707, Placebo - Alzheimer Disease | Phase 1 | Completed | Atridia Pty Ltd. | 50 | 2021-02-23 | 2022-07-12 |
| A Trial of SHR8735 in Healthy Subjects SHR8735 - Healthy Volunteers | Phase 1 | Completed | Atridia Pty Ltd. | 48 | 2021-02-11 | 2021-11-09 |
Showing 20 of 37. Sign in to see all of them.
Neoplasms (3) · Alzheimer Disease (2) · Asthma (2) · Gout (2) · Prostatic Neoplasms (2) · Psoriasis (2) · Acute Pain (1) · Breast Neoplasms (1) · Cardiomyopathy, Hypertrophic (1) · Chronic Urticaria (1) · Hematologic Neoplasms (1) · Hyperuricemia (1) · Inflammatory Bowel Diseases (1) · Influenza, Human (1) · Obesity (1)
fluzoparib (3) · ruzinurad (2) · Administration, Oral (1) · SHR-1701 (1) · camrelizumab (1)
Australia (37) · China (1) · South Korea (1) · Taiwan (1) · United States (1)
Ana Sun, Dr (1) · Dr Jasmine Daisy Williams (1) · Dr Richard Friend (1) · Na Li (1) · Neil Boudville, Ph.D (1) · Nicholas Farinola, B.Sc,BMBS (1) · Sam Salman, B.Sc,BMBS (1) · Sam Salman, B.Sc.BMBS (1)